Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Lakartidningen|May 13, 1999
[Centralized care is the basis of care programs for hemophilia patients]E Berntorp, S Lethagen, R Ljung, et al.
Cardiovascular and Interventional Radiology|November 11, 1999
In vivo study of polyurethane-coated Gianturco-Rosch biliary Z-stentsA Severini, S Mantero, M C Tanzi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2011
Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessmentE Berntorp, J Astermark, F Baghaei, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2001
An approach to study the viral safety of plasma-derived products in previously treated, non-infected patientsE Berntorp, P Petrini, G Dockter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2015
Using routine Haemophilia Joint Health Score for international comparisons of haemophilia outcome: standardization is neededA Nijdam, M Bladen, N Hubert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 22, 2006
Hemophilia joint health score reliability studyP Hilliard, S Funk, N Zourikian, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 22, 2012
von Willebrand's disease: a report from a meeting in the Åland islandsE Berntorp, I Peake, U Budde, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2006
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter studyG Castaman, F Rodeghiero, A Tosetto, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Experiences with continuous infusion of recombinant activated factor VIIS Schulman, R d'Oiron, U Martinowitz, et al.
Pageof 9